Literature DB >> 19851157

Effects of intensity of Transcutaneous Electrical Nerve Stimulation (TENS) on pressure pain threshold and blood pressure in healthy humans: A randomized, double-blind, placebo-controlled trial.

Lazaros Lazarou1, Athanasios Kitsios, Ioannis Lazarou, Evagelos Sikaras, Athanasios Trampas.   

Abstract

OBJECTIVES: Transcutaneous electrical nerve stimulation (TENS) is primarily used for pain relief. However, evidence is beginning to emerge that TENS may also have a lowering effect on systemic blood pressure (BP). The purpose of this study was to investigate the comparative effects of 2 intensities on pressure pain threshold (PPT) and resting BP in healthy humans, using low-frequency stimulation applied segmentally to the pain site.
METHODS: In a double-blind design, 40 volunteers, stratified by sex, were randomly allocated to 4 groups: high-intensity ("to tolerance without pain"), low-intensity ("strong but comfortable"), placebo, and control. TENS (2 Hz, 250 mu) was applied over the distribution of the superficial radial nerve of the dominant hand for 30 minutes. The outcome variables were measured at baseline and at 6 subsequent 10-minute intervals. For the PPTs, 2 measurements were taken bilaterally from the first dorsal interosseous muscle using a pressure algometer. The BP was measured in the brachial artery with an automatic monitor. Data difference scores were analyzed using repeated-measures and 1-way analyses of variance.
RESULTS: The high-intensity group showed a significant rise in PPT compared with the low-intensity, placebo, and control groups for both measurement sites, which sustained 30 minutes poststimulation. TENS produced no significant effect on BP, regardless of intensity. DISCUSSION: These results affirm that high levels of intensity are of fundamental importance in effective TENS dosage. This also applies for low frequency, segmental stimulation. Resting BP seems not to be dependent on intensity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851157     DOI: 10.1097/AJP.0b013e3181a7ece3

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  6 in total

1.  High-frequency transcutaneous peripheral nerve stimulation induces a higher increase of heat pain threshold in the cutaneous area of the stimulated nerve when confronted to the neighbouring areas.

Authors:  M Buonocore; N Camuzzini; M Cecini; E Dalla Toffola
Journal:  Biomed Res Int       Date:  2013-08-06       Impact factor: 3.411

2.  Influence of different frequencies of transcutaneous electrical nerve stimulation on the threshold and pain intensity in young subjects.

Authors:  Adriana de Oliveira Gomes; Ana Caroline Silvestre; Cristina Ferreira da Silva; Mariany Ribeiro Gomes; Maria Lúcia Bonfleur; Gladson Ricardo Flor Bertolini
Journal:  Einstein (Sao Paulo)       Date:  2014-09

Review 3.  Resolving Long-Standing Uncertainty about the Clinical Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) to Relieve Pain: A Comprehensive Review of Factors Influencing Outcome.

Authors:  Mark I Johnson
Journal:  Medicina (Kaunas)       Date:  2021-04-14       Impact factor: 2.430

4.  Effects of different frequencies of transcutaneous electrical nerve stimulation on venous vascular reactivity.

Authors:  O S Franco; F S Paulitsch; A P C Pereira; A O Teixeira; C N Martins; A M V Silva; R D M Plentz; M C Irigoyen; L U Signori
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

5.  Duration of Analgesia Induced by Acupuncture-Like TENS on Experimental Heat Pain.

Authors:  Yannick Tousignant-Laflamme; Marilyne Brochu; Cynthia Dupuis-Michaud; Catherine Pagé; Draga Popovic; Marie-Eve Simard
Journal:  ISRN Pain       Date:  2013-04-07

6.  Intensity matters: Therapist-dependent dose of spinal transcutaneous electrical nerve stimulation.

Authors:  Diego Serrano-Muñoz; Julio Gómez-Soriano; Elisabeth Bravo-Esteban; María Vázquez-Fariñas; Julian Taylor; Juan Avendaño-Coy
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.